5 August 2015

Plethora treatment wins NHS approval

15/04/2011 Ben Jaglom

Specialist pharmaceutical concern Plethora Solutions Holdings (PLE) says it has won approval for its vaginal dryness treatment Hyalofemme from the NHS for prescription.

The agreement means that doctors in the UK will now be able to write prescriptions for Hyalofemme for the first time for atrophic vaginitis, commonly referred to as vaginal dryness. Traditional treatments involve the use of hormonal creams containing estrogen, but such creams are often inappropriate for cancer patients, who often suffer vaginal dryness as a side effect of cancer treatment.

Chairman Bill Robinson remarks the decision by the NHS should 'increase the commercial value of our pipeline by exploiting products secured last year'. He adds that the release of Hyalofemme is an 'important treatment' for atrophic vaginitis.

Following the announcement analysts at house broker Daniel Stewart held their forecasts of a year-end loss of £1.3 million (2010: loss of £1.5 million) on revenue up £100,000 to £1.2 million. They have pencilled in a loss per share of 2.5p for 2011 and a further loss of 3.4p a share for 2012.

Shares in Plethora were up 0.25p this morning following the announcement to 7.5p, the price at which Growth Company Investor recommended them earlier this month. A good sign for the company's prospects, Hyalofemme will be prescribed both for those being treated for cancer and women going through the menopause. We therefore reiterate our speculative buy rating.

Tags: AIM market, Menopause, Pharma, Plethora Solutions Holdings, Urology Company, Vaginal dryness

Superb investment toolkit for private investors

SharePad is the new web-based service from ShareScope. Easier to use and more powerful. Perfect for tablets, Macs and Windows PC. Covers ALL your investment requirements.

Growth Company Investor: free trial

Since 2008, our share tips outperformed the benchmark by 281%. Take a free trial and get access to our recommendations today. Start free trial now.

Directors' Pay on AIM 2015

The most comprehensive review of AIM directors' pay available, and this year includes a record sample of 1000+ AIM-quoted companies. The full report is available to order for £385 + VAT. Click here for more info

 

Latest small-cap and growth company news

Daily coverage of small-cap company stocks on London's junior markets AIM and PLUS, breaking news, stock research and latest share price information for investors. Full sector coverage with all the latest news on smaller listed companies, updated several times a day with financial reports, trading statements and links to further web resources.

Popular News

Latest News

Quartix has enjoyed a strong start to life as a public company

Quartix focuses on US growth as earnings and profits soar 29/07/2015

Andy Walters, chief executive of telematics firm Quartix, has confirmed that the company will continue to focus on the fast-growth US market in the coming year as it reported improved earnings and profits. 

Petards Group shares nudge upwards as company hits targets  28/07/2015

Shares in Petards Group, a supplier of security technology, saw its shares rise by 2 per cent this morning as it confirmed that it is likely to hit its targets for the half-year to the end of June as a result of a switch to higher-margin products.

Earthport announces plan for Asian expansion  28/07/2015

AIM-listed financial technology firm Earthport confirmed this morning that it is to launch a new Asian headquarters in Singapore, with the aim of capitalising on the growth of South East Asia. 

Vast Resources sets its sights on Romania following fundraising  27/07/2015

AIM-listed resources company Vast Resources intends to use the £1.26 million it has raised from investors for a combination of corporate expenses and to expand its Romanian operations. 

SPARK Ventures raises £17 million and teams up with Gresham House for future growth  27/07/2015

AIM-listed SPARK Ventures, a company that invests in early-stage technology and digital information businesses, has announced that it has raised £17 million via a placing of new shares and an asset swap.

Nektan expects to beat forecasts when full-year results are released in September  20/07/2015

Online gaming technology firm Nektan Plc expects that its full-year results to the end of June 2015 will show a loss of around £5.5 million, which the company claims is 'better than expected'. 

More News